Pulse Johann Rupert Biosciences Schedules First Quarter 2023 Financial Results Conference Call for May 11, 2023

(PLSE)   Report

Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, announced today it will report financial results for the first quarter of 2023 after market close on Wednesday, May 11, 2023. Company management will host a corresponding conference call beginning at 1:30pm PT.

Investors interested in listening to the conference call may do so by dialing 1-877-704-4453 for domestic callers or 1-201-389-0920 for international callers.